Patrick R. Coyle
Pharmaceutical commercialization and Gross-to-Net advisor, founder of Novus Proximus
Charleston, South Carolina, United States
Actions
Patrick R. Coyle is a pharmaceutical commercialization and Gross-to-Net advisor with more than 25 years of finance leadership, 18 of them in the pharmaceutical industry at companies including Bayer, Novartis, Insmed, Eisai and IQVIA. He served as Vice President and Chief Financial Officer of Eisai Americas and led Gross-to-Net risk advisory at Baker Tilly.
He is founder and CEO of Novus Proximus, a healthcare commercialization advisory firm, and the creator of Patients + Profitability™, the philosophy that patient outcomes and sustainable profitability depend on each other. His frameworks include The 10 Exits of Therapy™, the ten points where a patient can delay or stop between diagnosis and a sustained start on therapy, and The 5 Layers of GTN™, taught through NextGen GTN™.
Patrick has spoken, moderated or served on panels at more than 25 industry conferences and hosts the Patients + Profitability™ podcast. More at patrickrcoyle.com.
Area of Expertise
Topics
Trace the Footsteps of Gross-to-Net Back to the Patient
Gross-to-Net is the financial echo of how well a company executed the patient journey. This session connects copay, coverage and fulfillment decisions to the numbers finance teams report.
Patients + Profitability™ Across the Product Lifecycle Phases
What commercial, market access, patient services and finance teams each need to get right from pre-launch through loss of exclusivity, and how to align them on one shared map.
Your Approval Rate Is Not Your Access Rate
Your approval rate is not your access rate. It describes the prescriptions that survived long enough to be measured. This session walks through The 10 Exits of Therapy™ and shows where patients leave between diagnosis and a sustained start on therapy, and where forecast revenue goes with them.
Please note that Sessionize is not responsible for the accuracy or validity of the data provided by speakers. If you suspect this profile to be fake or spam, please let us know.
Jump to top